Saltar al contenido
Solo para uso en investigación. No apto para uso humano ni veterinario. Analizado por HPLC de terceros · COA verificables por lote.
Centro de conocimiento
ProfileLongevityNAD+

NAD+ Research: Cellular Energy & Metabolic Pathways

6 min de lectura

NAD+ (nicotinamide adenine dinucleotide) isn't a peptide — it's a coenzyme found in every living cell — but it's a fixture of metabolic and longevity research, which is why it sits in this library. It's central to how cells convert nutrients into usable energy and to several pathways that decline with age. Educational reference summary only; no human use is described.

The cell's energy currency

NAD+ shuttles electrons in the reactions that extract energy from food, cycling between oxidized (NAD+) and reduced (NADH) forms. A landmark review framed NAD+ as a hub connecting metabolism, aging, and neurodegeneration (Verdin, Science, 2015). [1] When researchers talk about “cellular energy,” NAD+ is usually somewhere in the diagram.

Why it's central to aging research

Tissue NAD+ levels decline with age, and reviews describe how NAD+ metabolism governs processes implicated in ageing — including sirtuin activity and DNA-repair enzymes that consume NAD+ (Covarrubias et al., Nat Rev Mol Cell Biol, 2021). [2] That decline is the premise behind much of the field's interest.

NAD-boosting molecules

A large research effort examines whether raising NAD+ — via precursors and related molecules — affects age-related decline in animal models; reviews weigh the in-vivo evidence and its limits (Rajman, Chwalek & Sinclair, Cell Metab, 2018). [3]

Much NAD+ longevity evidence is preclinical and the human picture is still developing. Material is for laboratory Research Use Only — not for human or veterinary use.

Preguntas frecuentes

Is NAD+ a peptide?

No — it's a coenzyme (a dinucleotide). It's included here because it's a core molecule in the metabolic and longevity research that peptide researchers frequently study alongside.

Compuestos de investigación relacionados

Seguir leyendo